Direct-to-consumer genetic tests for heart disease
The results can be challenging to interpret, according to a scientific statement from the American Heart Association.
- Reviewed by Christopher P. Cannon, MD, Editor in Chief, Harvard Heart Letter; Editorial Advisory Board Member, Harvard Health Publishing
“Direct-to-consumer genetic tests provide more democratic access to this type of information. But because of several limitations, the findings aren’t always definitive, and there are potential downsides to using them,” says Dr. Leland Hull, assistant professor of medicine at Harvard Medical School and chair of the writing committee for the statement. Here’s a brief overview of these tests and what they can — and cannot — reveal about heart-related conditions.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
About the Author
Julie Corliss, Executive Editor, Harvard Heart Letter
About the Reviewer
Christopher P. Cannon, MD, Editor in Chief, Harvard Heart Letter; Editorial Advisory Board Member, Harvard Health Publishing
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
